ARMGO Pharma is developing a novel drug based on a new strategy for treating muscle weakness and degeneration in Duchenne MD, Becker MD and potentially other muscle disorders
New content is being added every day. Please check back again.
Muscular Dystrophy Association — USA National Office222 S. Riverside Plaza, Suite 1500Chicago, IL 60606(800) 572-1717
©2015, Muscular Dystrophy Association Inc. All rights reserved.